Seasonal Affective Disorder
Cluster Number:
Wiki Number: PW198
Diagnosis: Seasonal Affective Disorder
US Patients: 1.4% in Florida; 9.9% in Alaska
World Patients: Finland, 9.5%, Ireland, 20%
Sex Ratio:
Age Onset:
Brain Area: retinohypothalamic tract, suprachiasmatic nucleus, retina and pineal gland.
Symptoms: depressed in winter with over-sleeping, over-eating and too little energy, depressed thinking, loss of interest in activities
Progression:
Causes: lack of available natural light
Medications: SSRI’s, Vitamin D, and othrs
Therapies: light therapy, melatonin, ionized air administration and CBT. Due to skin cancer threat, direct sunlight should be avoided. Eat fish.
Youtube Video: How toknow if you have Seasonal Affective Disorder
Amazon or Library Book:
Ideas To Overcome Seasonal Affective Disorder
Click the book to link or order from Amazon.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosisÂ
Clicking each title opens the
PubMed article’s summary-abstract.
- Depression and obesity: Focus on factors and mechanistic linksby Ashley Selman on November 6, 2024
Major depressive disorder (MDD) is defined as mood disorder causing a persistent loss of interest and despair for two weeks or greater, with related symptoms. Depression can interfere with daily life and can cause those affected to not work, study, eat, sleep, and enjoy previously enjoyed hobbies and life events as they did previously. If untreated, it can become a serious health condition. Depression is multifactorial with a variety of factors influencing the condition. These factors include:...
- Tolerance of Bupropion SR After Delayed-Onset Urticaria and Angioedema Associated With Bupropion XLby Faisal R Elali on October 31, 2024
Bupropion is an atypical antidepressant indicated for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and smoking cessation. It is also used off-label for attention deficit hyperactivity disorder (ADHD). Its mechanism of action includes the selective norepinephrine and dopamine reuptake inhibitor (NDRI). The drug is available in immediate-release (IR), sustained-release (SR), and extended-release (XL) formulations. Common side effects are typically mild and...
- Circadian re-set repairs long-COVIDÂ in a prodromal Parkinson's parallel: a case seriesby Gregory L Willis on October 23, 2024
CONCLUSION: A light presentation protocol was adapted for long-COVID that not only restored sleep in all patients, but also unexpectedly repaired the depression, anxiety, and cognitive changes (brain fog) as well. A robust pattern of recovery commencing 4-5 days after treatment and was maintained for weeks to months without relapse. These preliminary findings represent a novel, minimally invasive approach for managing the most debilitating symptoms of long-COVID, making it an ideal candidate for...
- Factors associated with seasonal affective disorder: Findings from the bipolar disorder course and outcome study from India (BiD-CoIN study)by Sandeep Grover on October 20, 2024
CONCLUSION: Patients with SAD, in general, have more severe BD, and differ from those without SAD on many clinical parameters.